In committee
Stop Chinese Fentanyl Act of 2025
Chinese chemical companies and government officials who supply or turn a blind eye to ingredients used to make illicit fentanyl face severe U.S. financial penalties under this bill. The President can freeze their U.S.-based assets, bar them from entering the country, and cut them off from doing business with American banks and companies. To monitor the impact of these penalties, the bill requires regular evaluations of their economic costs and effectiveness, while prohibiting broad import bans on regular commercial goods.
People affected—not determinable from the text provided
Fiscal magnitude—not determinable from the text provided
Reach38provisional · pending reviewrigor: heuristic llm
What this bill touches.
Ethics & oversight+25Drugs & enforcement−35
Who it helps · who it burdens.
Who it helps
- Commercial importers of foreign goodsSection 5(a) explicitly bars the President from using the sanctions authorized or required under the Act to prohibit or restrict the physical importation of commercial goods into the United States.
Who it burdens
- Chinese chemical and drug manufacturing and shipping companiesSection 3(a) expands the legal definition of foreign opioid traffickers subject to U.S. sanctions to include Chinese entities that manufacture, sell, finance, or ship opioid materials without implementing know-your-customer procedures or cooperating with U.S. counternarcotics efforts.
- Senior Chinese government and regulatory officialsSections 3(a) and 3(b)(1) subject Chinese political and regulatory officials to U.S. sanctions if they fail to enforce laws against opioid trafficking, and specifically require the President to evaluate whether the heads of China's police, customs, medical, and narcotics agencies qualify for sanctions.
- Executive Office of the President and federal sanctions administratorsSections 3(b), 4(a), and 4(b)(3) require the President to conduct annual evaluations of emergency economic authorities concerning drug trafficking, extend trafficker reporting obligations to 10 years, and conduct cost-benefit analyses before issuing regulations under the International Emergency Economic Powers Act.